Bicara Therapeutics Inc. (BCAX)

Bicara Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	May 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	648	948	-	-
Enterprise Value	159	428	-	-
Last Close Price	11.89	17.42	-	-
Debt / Equity Ratio	0.00	0.00	0.00	-
Quick Ratio	27.22	27.22	15.28	0.17
Current Ratio	27.93	27.93	15.32	0.21
Return on Equity (ROE)	-19.14%	-19.14%	-51.67%	-
Return on Assets (ROA)	-13.84%	-13.84%	-20.72%	-
Return on Capital (ROIC)	-14.47%	-14.47%	-24.70%	-
Buyback Yield / Dilution	-2796.96%	-2796.96%	-35.20%	-

Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q